LifeStance Health Group, Inc.

LFSTNASDAQHealthcare● Active

$7.39

$-0.02(-0.27%)

Market Cap$2.9B

P/E Ratio—

52W High$8.89

52W Low$3.74

Avg Volume3.9M

Open$7.41

Beta1.19

Overview

LifeStance Health Group, Inc. (LFST) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

LFST · free cash flow · updated Jun 8, 2026

Core FCF metrics

LFST · FCF · TTM · margin & CAGR

Free cash flow was $110.0M for FY2025 (fiscal year ending 2025-12-31), up 28.4% year-over-year The FCF margin was 7.7%.

FY2025 Free Cash Flow$110.0M▲ +28.4% YoY

Trailing 12M (TTM)$178.8Mtrailing 4 quarters sum

FCF Margin7.7%$110.0M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

LFST · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$146.2M(36M)$110.0M▲ +28.4%7.7%

FY2024$107.3M(22M)$85.7M▲ +249.3%6.8%

FY2023−$16.9M(41M)−$57.4M▼ 116.9%-5.4%

FY2022$52.8M(79M)−$26.5M▲ +68.9%-3.1%

FY2021$9.4M(94M)−$85.1M▼ 82.6%-12.7%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

LFST · P/FCF · FCF yield · FCF per share

LifeStance Health Group, Inc. (LFST) trades at a FCF yield of 6.20% and a price-to-free-cash-flow ratio of 16.1x. FCF per share stands at $0.46, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

6.20%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.46

TTM FCF ÷ Shares Outstanding

Price / FCF

x16.1

Share Price ÷ FCF per Share

EV / FCF (TTM)

x16.1

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

LFST · cash flow statement · operating / investing / financing

For FY2025, LifeStance Health Group, Inc. generated $146.2M in operating cash flow and spent 36M in capital expenditures, yielding $110.0M in free cash flow.

Operating Activities

+$146.2M

Cash from core business operations

2025-12-31

Investing Activities

−$36.1M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$16.0M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($146.2M) − |CapEx| (36M) = FCF ($110.0M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

LFST vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

LifeStance Health Group, Inc.YOU

LFST

$110.0M+28.4%7.7%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

LifeStance Health Group, Inc. (LFST) reported free cash flow of $110.0M for FY2025 (fiscal year ending 2025-12-31), up 28.4% year-over-year. The FCF margin was 7.7%.

Based on available data, LifeStance Health Group, Inc. has maintained positive free cash flow for at least 3 fiscal year(s). FCF peaked at $110.0M in FY2025.

LifeStance Health Group, Inc.'s FCF yield is 6.20% and price-to-FCF ratio is 16.1x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

LFST free cash flow · 8 questions

LifeStance Health Group, Inc. free cash flow was $110.0M for FY2025, up 28.4% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $178.8M.

LFST free cash flowLFST FCFLFST FCF 2025LFST free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · LifeStance Health Group, Inc. · LifeStance Health Group, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026